Search research articles
Contact Us
Filters
Showing results (11-20 of 36) with videos related to
Page
of 4
Sort By:
Archives of Surgery (Chicago, Ill. : 1960)
|
May 1, 1992
Laparoscopic cholecystectomy. A clinical and financial analysis of 280 operations
M E Stoker, J Vose, P O'Mara, et al.
Bone Marrow Transplantation
|
November 1, 1990
Diabetes mellitus or an impaired glucose tolerance as a potential complicating factor in patients treated with high-dose therapy and autologous bone marrow transplantation
H C Schouten, D Maragos, J Vose, et al.
Leukemia & Lymphoma
|
January 1, 1997
2-Chlorodeoxyadenosine as initial therapy for advanced low grade lymphomas
V A Canfield, J Vose, P Guiney, et al.
Journal of Food Protection
|
June 19, 2019
Risk Assessment Model for Human Infection with the Cestode Taenia saginata
Peter B van der Logt, Steve C Hathaway, David J Vose
Transplantation
|
April 1, 1991
Transplantation of encapsulated allogeneic islets into diabetic BB/W rats. Effects of immunosuppression
R Mazaheri, P Atkison, C Stiller, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis
|
March 25, 2005
A linear model for managing the risk of antimicrobial resistance originating in food animals
Mary J Bartholomew, David J Vose, Linda R Tollefson, et al.
Leukemia & Lymphoma
|
May 9, 2001
A phase II multicenter study of CAMPATH-1H antibody in previously treated patients with nonbulky non-Hodgkin's lymphoma
A Khorana, P Bunn, P McLaughlin, et al.
HMO Practice
|
November 4, 1993
Hospitalized teens. Ambulatory care utilization patterns
N P Joshi, P O'Mara, T H Hendershott, et al.
The British Journal of Ophthalmology
|
October 19, 2002
Acute angle closure glaucoma following the use of intranasal cocaine during dacryocystorhinostomy
G A Wilcsek, M J Vose, I C Francis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1995
Phase I/II study incorporating intravenous hydroxyurea into high-dose chemotherapy for patients with primary refractory or relapsed and refractory intermediate-grade and high-grade malignant lymphoma
W P Vaughan, E Kris, J Vose, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 36) with videos related to
Sort By:
Page
of 4
Archives of Surgery (Chicago, Ill. : 1960)
|
May 1, 1992
Laparoscopic cholecystectomy. A clinical and financial analysis of 280 operations
M E Stoker, J Vose, P O'Mara, et al.
Bone Marrow Transplantation
|
November 1, 1990
Diabetes mellitus or an impaired glucose tolerance as a potential complicating factor in patients treated with high-dose therapy and autologous bone marrow transplantation
H C Schouten, D Maragos, J Vose, et al.
Leukemia & Lymphoma
|
January 1, 1997
2-Chlorodeoxyadenosine as initial therapy for advanced low grade lymphomas
V A Canfield, J Vose, P Guiney, et al.
Journal of Food Protection
|
June 19, 2019
Risk Assessment Model for Human Infection with the Cestode Taenia saginata
Peter B van der Logt, Steve C Hathaway, David J Vose
Transplantation
|
April 1, 1991
Transplantation of encapsulated allogeneic islets into diabetic BB/W rats. Effects of immunosuppression
R Mazaheri, P Atkison, C Stiller, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis
|
March 25, 2005
A linear model for managing the risk of antimicrobial resistance originating in food animals
Mary J Bartholomew, David J Vose, Linda R Tollefson, et al.
Leukemia & Lymphoma
|
May 9, 2001
A phase II multicenter study of CAMPATH-1H antibody in previously treated patients with nonbulky non-Hodgkin's lymphoma
A Khorana, P Bunn, P McLaughlin, et al.
HMO Practice
|
November 4, 1993
Hospitalized teens. Ambulatory care utilization patterns
N P Joshi, P O'Mara, T H Hendershott, et al.
The British Journal of Ophthalmology
|
October 19, 2002
Acute angle closure glaucoma following the use of intranasal cocaine during dacryocystorhinostomy
G A Wilcsek, M J Vose, I C Francis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1995
Phase I/II study incorporating intravenous hydroxyurea into high-dose chemotherapy for patients with primary refractory or relapsed and refractory intermediate-grade and high-grade malignant lymphoma
W P Vaughan, E Kris, J Vose, et al.
Page
of 4